In neurodegenerative diseases, CRISPR has been used to selectively knock out the mutant form of the huntingtin (HTT) gene, reducing the toxic protein burden and mitigating oxidative stress in neuronal cells [217]. The gene discussed is HTT; the disease is neurodegenerative disease.